Symbol
| PHA2B
|
Location
| 17q21.31
|
Name
|
familial hypertension and hyperkalemia, type 2 B |
Other name(s)
|
Gordon hyperkalemia-hypertension syndrome |
Corresponding gene
|
WNK4
|
Main clinical features
|
hyperchloremic acidosis, a normal glomerular filtration rate and low renin levels, responsive to thiazide diuretics, pseudohypoaldosteronism
chronic mineralocorticoid-resistant hyperkalemia with hypertension |
Genetic determination
| autosomal dominant |
Function/system disorder
| kidney and urinary tract |
Type
| disease
|
Name
| protein kinase, lysine deficient 4
|
Gene mutation | Chromosome rearrangement | Effect | Comments |
|
---|
missense
|  
| abnormal protein/gain of function
| missense mutations clustered close to the coiled-coil domain leading to a gain of function
| missense
|  
| abnormal protein/loss of function
| 564D>H, affects its interaction with the thiazide-sensitive target SLC12A3 and the potassium channel KCNJ1
| |
Remark(s)
|
. causing mutations disrupt potentially a Ca(2+)-sensing mechanism around the acidic motif necessary for the regulation of WNK4 kinase activity by Ca(2+) ions (PMID: 22342722)) |